News
Client MNRs and Landing Pages
Since 2004, brands have counted on Cision’s MultiVu to create and distribute their important news and marketing content to the world.
Let's talkSearch our recent client collaborations below:
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Dec 26, 2025It’s the holiday season, and everyone is busy fulfilling holiday gift lists and planning festive get-togethers, but there is one important family member who shouldn’t be forgotten: your pet!KEEP YOUR PET SAFE FROM COMMON HAZARDS THIS HOLIDAY SEASON For More Information It’s the holiday season, and everyone is busy fulfilling holiday gift lists and planning festive get-togethers,...
Dec 23, 2025MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCMLearn More CYTOKINETICS ANNOUNCES FDA APPROVAL OF MYQORZO™ (AFICAMTEN) FOR THE TREATMENT OF ADULTS WITH SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY MYQORZO, a Cardiac Myosin Inhibitor,...
Dec 22, 2025Boehringer Ingelheim’s JASCAYD® (nerandomilast) tablets has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of progressive pulmonary fibrosis (PPF) in adults.Boehringer Ingelheim’s JASCAYD® (nerandomilast) tablets has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of progressive pulmonary fibrosis (PPF) in adults.
Dec 19, 2025Through this exclusive collaboration, Hardy Diagnostics will introduce NEMIS's cutting-edge N-Light™ technology and advanced hygiene monitoring solutions to the North American market.Learn More Hardy Diagnostics Partners with NEMIS Technologies to Bring Rapid On-Site Pathogen Detection to North America SANTA MARIA, Calif., Dec. 18, 2025 -- Hardy Diagnostics, a leading...
Dec 19, 2025Company hosts 40+ local events to give back across its entire footprint
Connect with us: